News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
MarketBeat Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Kamada (KMDA) is presented as a potential value investment, currently holding a Zacks Rank #2 (Buy) and a Value grade of A. The article highlights several favorable valuation metrics for KMDA, including its P/E ratio, PEG ratio, and P/B ratio, which are all lower …
Kamada announced record first-half 2026 revenues of $100.2 million and adjusted EBITDA of $25.7 million, driven by strong demand for its specialty plasma-derived therapies. The company reaffirmed its full-year 2026 guidance and secured a new three-year, $50 million plasma supply agreement to support its …
Kamada Ltd. reported strong Q2 2026 financial results, with adjusted earnings of $0.16 per share, significantly exceeding the $0.11 consensus. The company's revenue increased by 23.0% to $54.9M, and it achieved a net income of $9.3M. Kamada also provided full-year revenue guidance of $200.0M …
Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA) announced that its Chief Financial Officer, Chaime Orlev, will transition out of his role on December 31, 2026, to pursue other opportunities. Orlev has served as CFO since 2017 and will assist in the transition to a successor, …
Kamada Ltd. Q2 2026 Earnings Call Summary - Moby Strategic Growth Pillars and Operational Execution Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap …
Sharemaestro market context Price below Trend Line 52 weeks -6.4%Kamada Ltd (KMDA) reported record revenues of $54.9 million in Q2 2026, a 23% year-over-year increase, and $100.2 million for H1 2026, marking its strongest quarter in company history. The company also achieved record adjusted EBITDA and net income, driven by strong cash generation, …
Sharemaestro market context Price below Trend Line 52 weeks -6.4%Kamada Ltd. reported record-high Q2 2026 results, surpassing Wall Street expectations with $0.16 EPS on $54.9 million revenue. The company achieved 23% year-over-year revenue growth and a 29% increase in adjusted EBITDA, driven by strong performance across its specialty plasma-derived products and disciplined expense …
Kamada Ltd. announced record-high financial results for the first half and second quarter of 2026, with double-digit growth in revenues and Adjusted EBITDA. The company reported first-half revenues of $100.2 million and Adjusted EBITDA of $25.7 million, and affirmed its 2026 annual guidance. This …
Kamada (NASDAQ: KMDA) announced that its Chief Financial Officer, Chaime Orlev, will step down on December 31, 2026, after nine years in the role, to pursue other opportunities. The company has initiated a search for his successor, and Orlev will provide transitional support. Kamada's …
Kamada Ltd. reported record first-half 2026 revenues of $100.2 million, marking a 13% increase year-over-year, driven by strong sales of KEDRAB, VARIZIG, and HEPAGAM. The biopharmaceutical company also announced a new three-year, $50 million plasma supply agreement and reaffirmed its annual revenue and adjusted …
Kamada Ltd. reported record financial results for the first half of 2026, with revenues of $100.2 million and adjusted EBITDA of $25.7 million, representing significant year-over-year growth. The company reaffirmed its full-year 2026 guidance for revenues between $200-$205 million and adjusted EBITDA of $50-$53 …
* Kamada (KMDA [https://seekingalpha.com/symbol/KMDA]) is scheduled to announce Q2 earnings results on Wednesday, August 12th, before market open. * The consensus EPS Estimate is $0.11 [https://seekingalpha.com/symbol/KMDA/earnings/estimates] (-15.4% Y/Y) and the consensus Revenue Estimate is $49.1M (+9.7% Y/Y). * Over the last 2 years, KMDA …
Sharemaestro market context Price below Trend Line 52 weeks -6.4%Kamada Ltd. is projected to report earnings of 11 cents per share, according to an earnings preview. This information is provided through TradingView News, which sources content from Reuters. The full article is available to subscribers of TradingView's news services.
Kamada (KMDA) is expected to report Q2 earnings of $0.12 per share, a 7.7% decline year-over-year, with revenues forecasted at $51.62 million, an increase of 15.4%. Analysts predict "Revenues-Distribution" at $10.55 million (+67% change) and "Revenues-Proprietary products" at $41.07 million (+6.9% change). The stock …
Ishay Davidi, a Director at Kamada (NASDAQ: KMDA), recently exercised stock options for 0 shares, valued at $0, as disclosed in an SEC filing on August 6, 2026. This transaction occurred while Kamada's shares were down by 0.14% at $7.17. The article also provides …
Assaf Itshayek, a Director at Kamada (NASDAQ: KMDA), exercised stock options for 0 shares, valued at $0, according to a recent SEC filing on August 6. This transaction occurred while Kamada shares were trading down 0.14% at $7.17. The article also provides a brief …
Kamada board member David Tsur exercised stock options for 0 shares, valued at $0, according to a recent SEC filing. The article highlights Kamada's strong financial performance, including a 2.78% revenue growth rate and a low debt-to-equity ratio of 0.04. It also emphasizes the …
Kamada Ltd. director Assaf Itshayek was granted 30,000 Employee Stock Options to acquire Ordinary Shares at an exercise price of $7.5200 per share. These options vest in four equal annual installments over four years and are exercisable for 10 years. The options are held …
This article from Investing.com reports on a Form 4 filing for KAMADA LTD related to August 6th. Form 4 filings are typically used to report changes in beneficial ownership of securities by company insiders. The article includes the stock symbol KMDA and notes a …
Uri Botzer, a director of Kamada Ltd, has been granted 30,000 employee stock options. This acquisition was reported in a statement of changes in beneficial ownership filed on August 6, 2026, with the options granted on August 5, 2026. This action falls under the …
Lilach Payorski, a Board Member at Kamada (NASDAQ: KMDA), recently exercised stock options for 0 shares, resulting in a value of $0. This information was disclosed in an SEC Form 4 filing on August 6, 2026. The article also provides a brief overview of …
Leon Recanati, a Director at Kamada (NASDAQ: KMDA), executed an options exercise for 0 shares, valued at $0, as revealed in an SEC filing on August 6, 2026. Despite this nominal transaction, the article highlights Kamada's strong financial performance, including a revenue growth rate …
Kamada Ltd. director Uri Botzer was granted 30,000 Employee Stock Options to purchase Ordinary Shares at an exercise price of $7.52 per share. These options will vest in four equal annual installments and are exercisable for 10 years from the grant date. The award …
Kamada Ltd. announced that its shareholders approved all proposals at the Annual General Meeting held on August 5, 2026, at the company's headquarters in Rehovot, Israel. These proposals included the re-election of directors, approval of option grants, an amendment to the U.S. Taxpayers Appendix …
Sharemaestro market context Price below Trend Line 52 weeks -6.4%Search by ticker symbol or company name and select a result to open its chart.